Format

Send to

Choose Destination
Thyroid. 2016 Oct;26(10):1515-1516. Epub 2016 Sep 27.

Sustained Response to Vemurafenib in a BRAFV600E-Mutated Anaplastic Thyroid Carcinoma Patient.

Author information

1
1 Department of Medicine I, Comprehensive Cancer Center Vienna; Medical University of Vienna , Vienna, Austria .
2
2 Institute of Clinical Pathology; Medical University of Vienna , Vienna, Austria .
3
3 Departments of Biomedical Imaging and Image-Guided Therapy; Medical University of Vienna , Vienna, Austria .
4
4 Department of Endocrine Surgery; Medical University of Vienna , Vienna, Austria .
PMID:
27532222
DOI:
10.1089/thy.2015.0575
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center